490 BioTech

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
Improve your research by converting endpoint assays to real-time data output. 490 BioTech’s self-activating bioluminescent technologies are drop in replacements for fluorescent/bioluminescent assays that allow any cell to continuously emit light and autonomously adjust intensity to reflect real-time changes in metabolism, toxicity, biomarker transcription, localization, differentiation state, or any desired cellular metric.

This breakthrough, called autobioluminescence, removes uneven excitation and emission in 3D culture applications, allows the distribution, health, and propagation of implanted cells to be tracked in real-time in animal models, eliminates fluorescent background, and removes the need to sacrifice precious samples concurrent with luciferin exposure. Enable new capabilities and accelerate your research by producing more data, reducing costs, and enabling continuous automated tracking using 490 BioTech’s autobioluminescent technology.
Company Type:
Company Website:
Company HQ State:
Tennessee
Company HQ Country:
United States
Year Founded:
2011
Main Therapeutic Focus:
Lead Product in Development:
Autobioluminescent Transfection Reagent
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Chief Scientific Officer
490 BioTech